DUBLIN--(BUSINESS WIRE)--The "Pharmacovigilance Europe Congress 2023" conference has been added to ResearchAndMarkets.com's offering.
After witnessing outstanding success in the previous Pharmacovigilance conferences, Pharmacovigilance Europe 2022 will gather the top notch Industry experts from Pharma/Biotech and Clinical Research Organisations.
Why Attend This Conference?
- Listen to the top Pharma/Biotech Industry pioneers who will deliver the latest cutting edge information.
- A fantastic opportunity to network with Pharma/Biotech Industry pioneers during the networking sessions.
- Speak-out sessions and Panel discussions will provide a great opportunity to ask questions from the expert and find out feasible solutions.
Current Market Of Global Pharmacovigilance
- 6 Billion Pharmacovigilance Market to reach $6 Billion in 2022
- 1,057 Billion Global Pharmaceutical Market Value $1057 Billion
Come and Update with the expanding Global Pharmaceutical Industry and increase awareness of the significant and essential need for Global Pharmacovigilance.
WHY ATTEND PHARMACOVIGILANCE EUROPE?
- A Global Event In Pharmacovigilance
- Ensuring Pharmacovigilance For Global Public Health
- 20+ Expert Speakers From Around The World
- 100'S Pharma/ Biotech Professionals From Over 50 Countries
- Bringing Together The Key Decision Makers Under One Roof
- Over 10 Hours Of Dedicated Networking And Interactive Sessions
Who Should Attend:
Pharmacovigilance Europe Congress 2023 attracts senior-level attendees from leading pharmaceutical, biopharmaceutical, biotechnology, diagnostics, CRO and solution provider companies. Delegates include VPs, Directors, Heads, Managers, Scientific Advisors, Consultants, Senior scientists and professionals with intermediate to advance knowledge and experience in the following.
- Pharmacovigilance Risk Management
- Drug Safety Pharmacoepidemiology
- Drug Research & Development Clinical Pharmacology
- Clinical Safety Information And Clinical Data Management
- Medical Product Safety Assessment Clinical Research & Safety
- Data Analysis Information Technology
- Medical Information Health Outcomes
- Sales And Marketing Clinical Trials & CRO's
- Contract Manufacturing
Speakers
Susan Welsh
Mirati Therapeutics - USA
Ricarda Tiemeyer
Biogen - Germany
Dr Mircea Ciuca
CSL Behring Switzerland
Kendal Harrison
MHRA - UK
Robert Masouh
PFIZER - UK
Jane Reed
Linguamatics - UK
Dawn Mucci
Jazz Pharmaceuticals - USA
Andrew Cooper
GSK - UK
Emanuel Lohrmann
OTSUKA - Germany
Pav Rishiraj
IPSEN - UK
Dr Jackie Roberts
Accord HealthCare
Uwe Gudat
Fresenius Kabi - Switzerland
Michael Bean
Johnson & Johnson - UK
Anna Fettiplace
Astra Zeneca - UK
Petar Gjorgiev
PFIZER - UK
Jennifer Kane
Flexion Therapeutics - USA
Khaudeja Bano
AMGEN - USA
Graeme Ladds
PharSafer - UK
Giovanni Furlan
PFIZER - Italy
Raj Bhogal
Jazz Pharmaceuticals - UK
Marylene Zhan
Accestra Consulting - China
For more information about this conference visit https://www.researchandmarkets.com/r/14w76j
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
